Marcie A Glicksman

This inventor holds 19 USPTO granted patents and 17 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in Stem Cell Research. Top assignees: The Brigham and Women's Hospital, Inc., Massachusetts Eye and Ear Infirmary, Sapphiros Ai Bio LLC. Active years: 2012-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marcie A Glicksman. Retrieved from https://idiyas.com/inventor/marcie-a-glicksman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 17)

% Patents Active = 73.7

CIPO Patents = 2 (Patent Applications = 6)

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 53(Granted Patents)

Location History:

Winchester, MA (US) (2012 - 2021)
Boston, MA (US) (2019 - 2024)

Company Filing History:

14 out of 1,428

The Brigham and Women's Hospital, Inc.

patents

5 out of 276

Massachusetts Eye and Ear Infirmary

Dana-Farber-Cancer Institute Inc.

patents

5. 2 out of 2

Yuma Therapeutics, Inc.

patents

6. 1 out of 2

Aquinnah Pharmaceuticals, Inc.

The Ohio State University

patents

where one patent can have more than one assignee

Years Active: 2012-2024

Loading Chart...

Areas of Expertise:

Induced Pluripotent Stem Cells

Cell Culture Media

Genetic Defects

Atoh1 Expression

Pyrimidine Compounds

Small Molecule Inhibitors

Parkinson's Disease

Spinal Muscular Atrophy

Phosphatidylcholine Transfer Protein

TDP-43 Inclusions

Eph B-3 Kinase

Pyridazine Derivatives

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12115037 - Systems and methods of assisted reproduction and prevention of genetic defects in offspring using induced pluripotent stem cells (2024-10-15),

2. 12087399 - Systems and methods for customizing cell culture media for optimized cell proliferation based on genetic traits of cells (2024-09-10),

3. 11692174 - Systems, methods, and apparatus for induced pluripotent stem cell isolation and combinatorial production (2023-07-04),

4. 11160808 - Compounds that enhance Atoh1 expression (2021-11-02),

5. 10961254 - Pyrimidine compounds and methods using the same (2021-03-30),

6. 10842822 - Diagnosis and treatment of parkinson's disease based on identification and amelioration of liver dysfunction (2020-11-24),

7. 10653676 - Small molecule inhibitors of USP1 deubiquitinating enzyme activity (2020-05-19),

8. 10406163 - Compounds that enhance Atoh1 expression (2019-09-10),

9. 10336768 - Pyrimidine compounds and methods using the same (2019-07-02),

10. 9556129 - Phosphatidylcholine transfer protein inhibitors (2017-01-31),

11. 9518032 - Small molecule inhibitors of USP1 deubiquitinating enzyme activity (2016-12-13),

12. 9447075 - Pyridazine derivatives as EAAT2 activators (2016-09-20),

13. 9433610 - Compounds that enhance Atoh1 expression (2016-09-06),

14. 9359363 - Identification of compounds that disperse TDP-43 inclusions (2016-06-07),

15. 9212209 - Screening methods for spinal muscular atrophy (2015-12-15),

Title: Marcie A Glicksman: Pioneering Innovations in Biotechnology

Introduction:

Marcie A Glicksman, a prominent inventor based in Boston, MA, is renowned for his unwavering passion for innovation and remarkable dedication to improving healthcare. With a remarkable portfolio of 17 patents, Glicksman has left an indelible mark in the biotechnology industry. His groundbreaking contributions continue to inspire budding inventors and researchers around the globe.

Latest Patents:

Among his latest patents is the revolutionary Systems, Methods, and Apparatus for Induced Pluripotent Stem Cell Isolation and Combinatorial Production. This innovative technology facilitates the systematic creation of isolated homogeneous colonies of cells from various vector-based lineages, paving the way for advancements in inducible pluripotent stem cell (iPSC) production. Additionally, Glicksman's invention of Compounds that Enhance Atoh1 Expression showcases his commitment to addressing diseases and disorders related to auditory impairments and abnormal cellular proliferation through targeted gene expression manipulation.

Career Highlights:

Having worked with esteemed institutions such as The Brigham and Women's Hospital, Inc. and Massachusetts Eye and Ear Infirmary, Glicksman has leveraged his expertise to drive forward cutting-edge research initiatives in the biotechnology realm. His illustrious career underscores a relentless pursuit of scientific excellence and a deep-seated commitment to revolutionizing healthcare through innovative solutions.

Collaborations:

Throughout his career, Glicksman has collaborated with distinguished professionals in the field, including Gregory Cuny and Lixin Qiao. These collaborative efforts have synergistically contributed to the development of groundbreaking technologies and propelled advancements in biotechnology research.

Conclusion:

In conclusion, Marcie A Glicksman's remarkable journey as an inventor in the biotechnology industry embodies a profound dedication to innovation and a relentless pursuit of excellence. His pioneering spirit and transformative inventions serve as a beacon of inspiration for the scientific community, paving the way for a brighter and healthier future.

Profile summary based on public USPTO records.